Ionis Pharmaceuticals, Inc. (IONS)
NASDAQ·Healthcare·Biotechnology
$71.53
-0.98%
Mkt Cap $12.35B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 25, 2026 | $156.07M | $203.00M | +30.07% | -$1.24 | -$1.41 | -14.02% | — | — |
| Q4 2025 Oct 29, 2025 | $153.57M | $156.72M | +2.05% | -$1.15 | -$0.61 | +46.96% | — | — |
| Q3 2025 Jul 30, 2025 | $131.75M | $452.05M | +243.12% | $0.27 | $0.86 | +218.52% | — | — |
| Q2 2025 Apr 30, 2025 | $150.59M | $131.61M | -12.60% | -$1.11 | -$0.75 | +32.43% | — | — |
| Q1 2025 Feb 19, 2025 | $131.14M | $226.58M | +72.78% | -$1.09 | -$0.66 | +39.45% | — | — |
| Q4 2024 Nov 6, 2024 | $144.44M | $133.81M | -7.36% | -$1.16 | -$0.95 | +18.10% | — | — |
| Q3 2024 Aug 1, 2024 | $150.07M | $225.25M | +50.10% | -$0.92 | -$0.45 | +51.09% | — | — |
| Q2 2024 May 7, 2024 | $131.42M | $119.00M | -9.45% | -$1.05 | -$0.98 | +6.44% | — | — |
| Q1 2024 Feb 21, 2024 | $174.76M | $324.50M | +85.69% | -$0.83 | -$0.06 | +92.77% | — | — |
| Q4 2023 Nov 2, 2023 | $132.90M | $144.21M | +8.51% | -$1.04 | -$1.03 | +0.96% | — | — |
| Q3 2023 Aug 9, 2023 | $138.83M | $188.41M | +35.71% | -$0.90 | -$0.60 | +33.33% | — | — |
| Q2 2023 May 3, 2023 | $140.51M | $130.52M | -7.11% | -$0.91 | -$0.87 | +4.40% | — | — |
| Q1 2023 Feb 22, 2023 | $160.13M | $151.89M | -5.14% | -$1.06 | -$0.37 | +65.09% | — | — |
| Q4 2022 Nov 9, 2022 | $143.95M | $159.77M | +10.99% | -$0.74 | -$0.33 | +55.41% | — | — |
| Q3 2022 Aug 9, 2022 | $140.54M | $133.79M | -4.80% | -$0.62 | -$0.74 | -19.35% | — | — |
| Q2 2022 May 4, 2022 | $122.46M | $141.92M | +15.89% | -$0.71 | -$0.46 | +35.21% | — | — |
| Q1 2022 Feb 24, 2022 | $275.55M | $440.01M | +59.68% | $0.28 | $1.41 | +403.57% | — | — |
| Q4 2021 Nov 3, 2021 | $163.67M | $133.09M | -18.68% | -$0.53 | -$0.58 | -9.43% | — | — |
| Q3 2021 Aug 4, 2021 | $126.00M | $125.75M | -0.20% | -$0.60 | -$0.57 | +5.00% | — | — |
| Q2 2021 May 5, 2021 | $138.50M | $111.61M | -19.42% | -$0.53 | -$0.64 | -20.75% | — | — |